{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:31:03Z","timestamp":1779291063727,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Guangxi medical and health appropriate technology development and promotion application project","award":["S201657"],"award-info":[{"award-number":["S201657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s13304-022-01376-5","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T07:02:41Z","timestamp":1663484561000},"page":"1805-1816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with\/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"74","author":[{"given":"Huachu","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baibei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"1376_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","volume":"42","author":"P Correa","year":"2013","unstructured":"Correa P (2013) Gastric cancer: overview. Gastroenterol Clin N Am 42:211\u2013217","journal-title":"Gastroenterol Clin N Am"},{"issue":"3","key":"1376_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 71(3):209\u2013249","journal-title":"CA: Cancer J Clin"},{"issue":"1","key":"1376_CR3","first-page":"5","volume":"40","author":"WQ Chen","year":"2018","unstructured":"Chen WQ, Li H, Sun KX et al (2018) Report of cancer incidence and mortality in China, 2014 Zhonghua zhong liu za zhi. Chin J Oncol 40(1):5\u201313","journal-title":"Chin J Oncol"},{"issue":"2","key":"1376_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000350877","volume":"30","author":"K Fujitani","year":"2013","unstructured":"Fujitani K (2013) Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East. Dig Surg 30(2):119\u2013129","journal-title":"Dig Surg"},{"issue":"6","key":"1376_CR5","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/cam4.2204","volume":"88","author":"R Yarema","year":"2019","unstructured":"Yarema R, Mielko J, Fetsych T et al (2019) Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitoneally disseminated gastric cancer: a retrospective cooperative central-Eastern European study. Cancer Med 45:144","journal-title":"Cancer Med"},{"issue":"1\u20132","key":"1376_CR6","first-page":"93","volume":"23","author":"GZ Zheng","year":"2006","unstructured":"Zheng GZ, Rui T, Min Y et al (2006) Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study Dig Surg 23(1\u20132):93\u2013102","journal-title":"A long-term follow-up study Dig Surg"},{"issue":"2","key":"1376_CR7","first-page":"256","volume":"40","author":"JS Spratt","year":"1980","unstructured":"Spratt JS, Adcock RA, Muskovin M et al (1980) Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Can Res 40(2):256\u2013260","journal-title":"Can Res"},{"key":"1376_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejogrb.2019.10.047","volume":"244","author":"A Mar","year":"2020","unstructured":"Mar A, Jpm B, Rb C et al (2020) A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 244:101\u2013105","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"1376_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"C Klaver","year":"2019","unstructured":"Klaver C, Wisselink DD, Punt C et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 4(10):761\u2013770","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1376_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejso.2020.01.032","volume":"47","author":"D Cort\u00e9s-Guiral","year":"2020","unstructured":"Cort\u00e9s-Guiral D, Mohamed F, Glehen O et al (2020) \"Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Eur J Surg Oncol 47(1):60\u201364","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1376_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.soc.2018.02.006","volume":"27","author":"FS Dahdaleh","year":"2018","unstructured":"Dahdaleh FS, Turaga KK (2018) Evolving treatment strategies and outcomes in advanced gastric cancer with peritoneal metastasis. Surg Oncol Clin N Am 27(3):519\u2013537","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"1376_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5219-3","volume":"19","author":"MK Beeharry","year":"2019","unstructured":"Beeharry MK, Zhu ZL, Liu WT et al (2019) Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer 19(1):1\u20133","journal-title":"BMC Cancer"},{"issue":"2","key":"1376_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jso.23062","volume":"106","author":"N Golse","year":"2012","unstructured":"Golse N, Bakrin N, Passot G et al (2012) Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. J Surg Oncol 106(2):197\u2013203","journal-title":"J Surg Oncol"},{"key":"1376_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","volume":"48","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev 48:42\u201349","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1376_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):1\u201311","journal-title":"Syst Rev"},{"key":"1376_CR16","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Altman DG, Gtzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","DOI":"10.1136\/bmj.d5928"},{"key":"1376_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S, Hamazoe R, Maeta M et al (1988) Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61:232\u2013237","journal-title":"Cancer"},{"issue":"2","key":"1376_CR18","first-page":"75","volume":"36","author":"N Kaibara","year":"1989","unstructured":"Kaibara N, Hamazoe R, Iitsuka Y et al (1989) Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer. Hepatogastroenterology 36(2):75\u201378","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"1376_CR19","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q","volume":"73","author":"R Hamazoe","year":"2015","unstructured":"Hamazoe R, Maeta M, Kaibara N (2015) Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 73(8):2048\u20132052","journal-title":"Cancer"},{"issue":"1","key":"1376_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00348209","volume":"18","author":"T Fujimura","year":"1994","unstructured":"Fujimura T, Yonemura Y, Muraoka K et al (1994) Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 18(1):150","journal-title":"World J Surg"},{"issue":"8","key":"1376_CR21","first-page":"581","volume":"161","author":"M Ikeguchi","year":"1995","unstructured":"Ikeguchi M, Kondou A, Oka A et al (1995) Effect of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 161(8):581\u2013586","journal-title":"Eur J Surg"},{"issue":"3","key":"1376_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","volume":"85","author":"S Fujimoto","year":"2015","unstructured":"Fujimoto S, Takahashi M, Mutou T et al (2015) Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 85(3):529\u2013534","journal-title":"Cancer"},{"issue":"42","key":"1376_CR23","first-page":"1776","volume":"48","author":"Y Yonemura","year":"2001","unstructured":"Yonemura Y, Aretxabala XD, Fujimura T et al (2001) Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48(42):1776\u20131782","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"1376_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6):1575\u20131581","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1376_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/etm.2014.1599","volume":"7","author":"H Cui","year":"2014","unstructured":"Cui H, Ge H, Bai X et al (2014) Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer. Exp Ther Med 7(5):1083\u20131088","journal-title":"Exp Ther Med"},{"issue":"2","key":"1376_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12013-014-0326-5","volume":"71","author":"O Huang","year":"2015","unstructured":"Huang O, Lu XH, Xu XD et al (2015) Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-ii clinical trial with a 40-month follow-up. Cell Biochem Biophys 71(2):1171\u20131180","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"1376_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE et al (2014) Impact of maximal cytoreductive surgery plus regional heated intra-peritoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110(3):275\u2013284","journal-title":"J Surg Oncol"},{"key":"1376_CR28","first-page":"299","volume":"63","author":"C Lu","year":"2016","unstructured":"Lu C, Li L, Luo Z et al (2016) Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites. Neoplasma 63:299\u2013303","journal-title":"Neoplasma"},{"issue":"1","key":"1376_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","volume":"21","author":"B Fan","year":"2021","unstructured":"Fan B, Bu Z, Zhang J et al (2021) Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer 21(1):216","journal-title":"BMC Cancer"},{"key":"1376_CR30","first-page":"l4898","volume":"366","author":"J Sterne","year":"2019","unstructured":"Sterne J, Savovi J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ Clin Res 366:l4898","journal-title":"BMJ Clin Res"},{"issue":"14","key":"1376_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMc1802033","volume":"378","author":"B Afsar","year":"2018","unstructured":"Afsar B, Kanbay M (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(14):1362","journal-title":"N Engl J Med"},{"issue":"5","key":"1376_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jso.21619","volume":"102","author":"A Nissan","year":"2010","unstructured":"Nissan A, Garofalo A, Esquivel J (2010) Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven\u2019t we reached the promised land? J Surg Oncol 102(5):359\u2013360","journal-title":"J Surg Oncol"},{"issue":"Suppl 1","key":"1376_CR33","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.21037\/jgo-20-129","volume":"12","author":"MY Reutovich","year":"2021","unstructured":"Reutovich MY, Krasko OV, Sukonko OG (2021) Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review. J Gastrointest Oncol 12(Suppl 1):S5\u2013S17","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"1376_CR34","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.21037\/jgo-20-262","volume":"12","author":"Z Ji","year":"2021","unstructured":"Ji Z, Zhang Y, Li Y (2021) Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review. J Gastrointest Oncol 12(1):S70\u2013S78","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"1376_CR35","first-page":"1547","volume":"22","author":"N Pallas","year":"2017","unstructured":"Pallas N, Karamveri C, Kyziridis D et al (2017) Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis. J BUON: Off J Balk Union Oncol 22(6):1547\u20131553","journal-title":"J BUON: Off J Balk Union Oncol"},{"key":"1376_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11596-009-0205-2","volume":"29","author":"N Di","year":"2009","unstructured":"Di N, Liu F et al (2009) Destruction of gastric cancer cells to mesothelial cells by apoptosis in the early peritoneal metastasis. J Huazhong Univ Sci Technol Med Sci 29:163\u2013168","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"1376_CR37","unstructured":"Liu G, Huang JP (2011) The clinical analysis of laparoscopic assisted D_2 radical gastrectomy for progressed gastric carcinoma. Chin J Mod Op Surg 15(5):355-357"},{"key":"1376_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio J, Chao J, Melstrom L et al (2017) The thirty-year experience - a meta-analysis of randomized and high-quality non-randomized studies of hyperthermic intraperitoneal chemotherapy(HIPEC) in the treatment of gastric cancer. Eur J Cancer 79:1\u201314","journal-title":"Eur J Cancer"},{"issue":"12","key":"1376_CR39","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1177\/0300060519882545","volume":"47","author":"Y-W Liu","year":"2019","unstructured":"Liu Y-W, Ying Du et al (2019) Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials. J Int Med Res 47(12):5926\u20135936","journal-title":"J Int Med Res"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01376-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-022-01376-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01376-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T04:14:55Z","timestamp":1668831295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-022-01376-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1007\/s13304-022-01376-5","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}